Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intramolecular Oxidoreductases | 3 | 2002 | 57 | 0.360 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2002 | 136 | 0.350 |
Why?
|
| Anemia, Sideroblastic | 1 | 2021 | 17 | 0.190 |
Why?
|
| Antibody Specificity | 2 | 2002 | 202 | 0.180 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 1996 | 61 | 0.160 |
Why?
|
| Genes, ras | 2 | 1996 | 98 | 0.160 |
Why?
|
| Microcephaly | 1 | 2022 | 332 | 0.160 |
Why?
|
| Antibodies | 1 | 2000 | 371 | 0.160 |
Why?
|
| Models, Molecular | 2 | 2002 | 1074 | 0.150 |
Why?
|
| Aggrecans | 1 | 2017 | 4 | 0.140 |
Why?
|
| Dwarfism | 1 | 2017 | 100 | 0.130 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2014 | 33 | 0.120 |
Why?
|
| Receptors, Ghrelin | 1 | 2012 | 29 | 0.100 |
Why?
|
| Endocrinology | 1 | 2014 | 136 | 0.100 |
Why?
|
| Ghrelin | 1 | 2012 | 54 | 0.100 |
Why?
|
| Leptin | 1 | 2012 | 214 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2022 | 101 | 0.090 |
Why?
|
| Mutation | 3 | 2021 | 5805 | 0.080 |
Why?
|
| Peptide Fragments | 4 | 2002 | 754 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1261 | 0.070 |
Why?
|
| Glucose | 1 | 2012 | 885 | 0.070 |
Why?
|
| Membrane Proteins | 3 | 2000 | 1529 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 2701 | 0.070 |
Why?
|
| Pedigree | 2 | 2022 | 1596 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2000 | 3875 | 0.060 |
Why?
|
| Pediatrics | 1 | 2014 | 1154 | 0.060 |
Why?
|
| Phenotype | 3 | 2021 | 4257 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 2 | 2002 | 219 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 63 | 0.050 |
Why?
|
| Histidine | 1 | 2022 | 72 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2002 | 833 | 0.050 |
Why?
|
| Transfection | 2 | 2002 | 1069 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2021 | 44 | 0.050 |
Why?
|
| Circular Dichroism | 2 | 1998 | 86 | 0.050 |
Why?
|
| Muscle Hypotonia | 1 | 2022 | 188 | 0.040 |
Why?
|
| Prostaglandins H | 1 | 2000 | 4 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 2267 | 0.040 |
Why?
|
| Prostaglandin H2 | 1 | 2000 | 12 | 0.040 |
Why?
|
| Liposomes | 2 | 1998 | 170 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2000 | 157 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 459 | 0.040 |
Why?
|
| Diethylnitrosamine | 2 | 1996 | 17 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2000 | 291 | 0.040 |
Why?
|
| Exons | 1 | 2022 | 796 | 0.040 |
Why?
|
| Rats, Inbred F344 | 2 | 1996 | 105 | 0.040 |
Why?
|
| Fever | 1 | 2021 | 296 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1999 | 204 | 0.040 |
Why?
|
| Epitopes | 1 | 2000 | 432 | 0.040 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 1998 | 7 | 0.040 |
Why?
|
| Eicosanoids | 1 | 1998 | 13 | 0.040 |
Why?
|
| Cell Division | 1 | 1999 | 781 | 0.040 |
Why?
|
| Thromboxane-A Synthase | 1 | 1998 | 16 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 1998 | 238 | 0.040 |
Why?
|
| Animals | 6 | 2012 | 34154 | 0.040 |
Why?
|
| Binding Sites | 1 | 2000 | 1296 | 0.040 |
Why?
|
| Osteochondritis Dissecans | 1 | 2017 | 4 | 0.030 |
Why?
|
| Brachydactyly | 1 | 2017 | 10 | 0.030 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2017 | 13 | 0.030 |
Why?
|
| Rabbits | 1 | 1998 | 711 | 0.030 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2017 | 18 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1999 | 468 | 0.030 |
Why?
|
| Growth | 1 | 2017 | 106 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1996 | 145 | 0.030 |
Why?
|
| Growth Hormone | 1 | 2017 | 153 | 0.030 |
Why?
|
| Cyclins | 1 | 1996 | 101 | 0.030 |
Why?
|
| Anthropometry | 1 | 2017 | 198 | 0.030 |
Why?
|
| Cocarcinogenesis | 1 | 1995 | 23 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 1998 | 756 | 0.030 |
Why?
|
| ras Proteins | 1 | 1996 | 136 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 646 | 0.030 |
Why?
|
| Cell Line | 1 | 2000 | 2773 | 0.030 |
Why?
|
| Models, Biological | 1 | 2000 | 1459 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 785 | 0.030 |
Why?
|
| Heterozygote | 1 | 2017 | 676 | 0.030 |
Why?
|
| Humans | 7 | 2022 | 124488 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1995 | 357 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 1995 | 220 | 0.030 |
Why?
|
| Child | 3 | 2022 | 24438 | 0.030 |
Why?
|
| Apoptosis | 1 | 1999 | 1787 | 0.030 |
Why?
|
| Rats | 2 | 1996 | 3685 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2012 | 78 | 0.020 |
Why?
|
| Male | 5 | 2022 | 61052 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 209 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 631 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2012 | 222 | 0.020 |
Why?
|
| Metabolome | 1 | 2012 | 294 | 0.020 |
Why?
|
| Liver | 1 | 1996 | 1761 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 795 | 0.020 |
Why?
|
| Homeostasis | 1 | 2012 | 692 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 2506 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6484 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 3753 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 4426 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 8971 | 0.010 |
Why?
|
| Microsomes | 1 | 2002 | 55 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 2002 | 98 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2002 | 105 | 0.010 |
Why?
|
| COS Cells | 1 | 2002 | 276 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 12473 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 14042 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 1321 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1999 | 59 | 0.010 |
Why?
|
| Mice | 2 | 2012 | 17733 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 19552 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 19302 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1392 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1999 | 246 | 0.010 |
Why?
|
| Micelles | 1 | 1998 | 20 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 1064 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 1999 | 260 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 340 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 26514 | 0.010 |
Why?
|
| Glucose-6-Phosphatase | 1 | 1996 | 17 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1996 | 129 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1996 | 82 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 290 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1998 | 572 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 29397 | 0.010 |
Why?
|
| Carcinogens | 1 | 1996 | 153 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1999 | 1626 | 0.010 |
Why?
|
| Protein Binding | 1 | 1998 | 1750 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1996 | 940 | 0.010 |
Why?
|
| Female | 1 | 2017 | 66318 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1996 | 1899 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1999 | 4535 | 0.000 |
Why?
|